Innocoll Biotherapeutics

📍 Princeton, United States🗓 Founded 1985👥 18 employees💰 Last funded Jun 2022
Pharmaceutical Manufacturing🌐 innocoll.com
Website LinkedIn
Innocoll is committed to improving patient care by confronting some of today’s most important healthcare challenges. Everyone at Innocoll is united by a common goal: to deliver healthcare solutions that make a difference in patients’ lives. We take pride in fostering a culture of collaboration, and we strive to be the best possible partners to the hospitals and doctors we support. Our current late-stage product pipeline, including XARACOLL (bupivacaine HCl) implant and POSIMIR (bupivacaine solution) for infiltration use, are focused on addressing patient needs for postsurgical pain management.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1985
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Innocoll Biotherapeutics?
Innocoll Biotherapeutics has 1 investors on record on gritt.io.
When did Innocoll Biotherapeutics last raise funding?
The most recent investment in Innocoll Biotherapeutics recorded on gritt.io was in June 2022.
When was Innocoll Biotherapeutics founded?
Innocoll Biotherapeutics was founded in 1985.
What industry is Innocoll Biotherapeutics in?
Innocoll Biotherapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Innocoll Biotherapeutics based?
Innocoll Biotherapeutics is headquartered in Princeton, United States.